Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by Riverfolk


V.ARCH

Arch Biopartners - My Due Diligence (NEW)

Arch Biopartners Inc. is a clinical stage company focused on the development...

December 30, 2021

V.ARCH

ARCH - Minister Copping

“The drug candidate from Arch Biopartners, which has the generic name LSALT...

December 30, 2021

V.ARCH

ARCH - PM Justin Trudeau

{^youtubevideo|(width)425|(height)264|(rel)False|(url)https://www...

December 30, 2021

V.ARCH

ARCH - Premier Kenney

Great to see this made-in-Alberta COVID-19 drug move ahead to national human...

December 30, 2021

V.ARCH

ARCH - The Honourable Navdeep Bains

“As the world works toward an effective COVID-19 vaccine, we cannot lose...

December 30, 2021

V.ARCH

Arch - The Honourable Franois-Philippe Champagne

“Our support for Arch Biopartners’ development of their COVID-19...

December 30, 2021

V.ARCH

MetaBlok - A Pathway to an unmet 20 billion market

Recently Arch Biopartners released a glimpse of the human data waiting on...

December 30, 2021

V.ARCH

$3.35- Extremely Undervalued in Comparison to Phase II peers

lets not forget that we are extremely undervalued compared to our Phase II...

December 30, 2021

V.ARCH

Todays House Positions

House Positions for C:ARCH from 20211230 to 20211230...

December 30, 2021

V.ARCH

Merry Christmas & Happy New Year

What a year of achievements for management and in return shareholders have...

December 25, 2021

V.ARCH

Tril - Arch

December 23, 2021

V.ARCH

$3.75- Extremely Undervalued in Comparison to Phase II peers

The recent realization by the market has made the Arch chart look incredible,...

December 23, 2021

V.ARCH

MetaBlok - A Pathway to an unmet 20 billion market

Recently Arch Biopartners released a glimpse of the human data waiting on...

December 23, 2021

V.ARCH

RE:New to this board

Riverfolk wrote: I have been following this play since June, jumped in at the...

December 20, 2021

V.ARCH

Arch Shareholders

This stock is my largest holding, I have been on this board for 4 years while...

December 20, 2021

V.ARCH

MetaBlok - A Pathway to an unmet 20 billion market

This past week Arch Biopartners released a glimpse of the human data waiting...

December 20, 2021

V.ARCH

Arch Biopartners - My Due Diligence (NEW)

Arch Biopartners Inc. is a clinical stage company focused on the development...

December 20, 2021

V.ARCH

Another Reason Why this is my largest holding - Insider Buy

Dec 8/21 CEO Muruve, Richard Gabriel Direct Ownership Public market buy...

December 11, 2021

V.ARCH

Todays House Positions

House Positions for C:ARCH from 20211209 to 20211209 ...

December 9, 2021

V.ARCH

Arch Biopartners - A Team That Executes

May 8, 2018 - $.52 Arch Bio Completes Pre-IND Meeting with FDA on LSALT ...

December 9, 2021

Featured Company